The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......
The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......
The coming together of India's two very large drug makers, Sun Pharmaceutical Industries and Ranbaxy Laboratories, has created a stir in the pharmaceutical world. Sun's $3.2-billion all-share......